![]() |
Volumn 184, Issue , 2010, Pages 3-20
|
Imatinib Mesylate
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 [2 METHYL 5 [4 (1 PIPERAZINYLMETHYL)BENZAMIDO]ANILINO] 4 (3 PYRIDYL)PYRIMIDINE;
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
CARBAMAZEPINE;
CLARITHROMYCIN;
CYCLOSPORIN;
CYTARABINE;
DASATINIB;
DEXAMETHASONE;
ERYTHROMYCIN;
HOMOHARRINGTONINE;
IMATINIB;
ITRACONAZOLE;
KETOCONAZOLE;
NILOTINIB;
PHENOBARBITAL;
PHENYTOIN;
PROTEIN TYROSINE KINASE INHIBITOR;
RECOMBINANT ALPHA INTERFERON;
RECOMBINANT INTERFERON;
RIFAMPICIN;
SIMVASTATIN;
ABDOMINAL PAIN;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALLOGENEIC STEM CELL TRANSPLANTATION;
ANEMIA;
ANOREXIA;
ANTINEOPLASTIC ACTIVITY;
AREA UNDER THE CURVE;
ARTHRALGIA;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
ASTHENIA;
BLEEDING;
BONE MARROW SUPPRESSION;
BRAIN HEMORRHAGE;
CARDIOTOXICITY;
CHEMICAL STRUCTURE;
CHEMOTHERAPY INDUCED EMESIS;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CONSTIPATION;
COUGHING;
CYTOGENETICS;
DIARRHEA;
DISEASE COURSE;
DISEASE SEVERITY;
DIZZINESS;
DRUG BINDING;
DRUG BLOOD LEVEL;
DRUG DOSE ESCALATION;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG ERUPTION;
DRUG HALF LIFE;
DRUG INDUCED HEADACHE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG SAFETY;
DRUG TARGETING;
DRUG TOLERABILITY;
DYSPEPSIA;
DYSPNEA;
ECCHYMOSIS;
EDEMA;
EPISTAXIS;
FATIGUE;
FEVER;
FLUID RETENTION;
GASTROINTESTINAL HEMORRHAGE;
GASTROINTESTINAL STROMAL TUMOR;
GENE AMPLIFICATION;
GENE MUTATION;
GENE OVEREXPRESSION;
HEART FAILURE;
HEART LEFT VENTRICLE FAILURE;
HUMAN;
HYPOKALEMIA;
IN VITRO STUDY;
INFLUENZA;
INSOMNIA;
MAXIMUM TOLERATED DOSE;
MONOTHERAPY;
MUSCLE CRAMP;
MUSCULOSKELETAL PAIN;
MYALGIA;
NAUSEA;
NEUTROPENIA;
NIGHT SWEAT;
OVERALL SURVIVAL;
PETECHIA;
PHARMACOLOGICAL PARAMETERS;
PNEUMONIA;
PRIORITY JOURNAL;
PROGNOSIS;
PROGRESSION FREE SURVIVAL;
PROTEIN PHOSPHORYLATION;
PRURITUS;
RECOMMENDED DRUG DOSE;
REMISSION;
REVIEW;
RHINOPHARYNGITIS;
RIGOR;
SIDE EFFECT;
SIGNAL TRANSDUCTION;
SORE THROAT;
THROMBOCYTOPENIA;
TREATMENT DURATION;
TREATMENT RESPONSE;
UPPER RESPIRATORY TRACT INFECTION;
WEAKNESS;
WEIGHT GAIN;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DISEASE PROGRESSION;
DRUG RESISTANCE, NEOPLASM;
GASTROINTESTINAL STROMAL TUMORS;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
NEOPLASMS;
PIPERAZINES;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
|
EID: 77953655360
PISSN: 00800015
EISSN: None
Source Type: Book Series
DOI: 10.1007/978-3-642-01222-8_1 Document Type: Review |
Times cited : (66)
|
References (19)
|